Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case

QR Code

Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case

This article describes a case of successfully used tocilizumab (interleukin 6 receptors monoclonal antibodies) in a two-year patient with severe systemic juvenile idiopathic arthritis resistant to oral and parenteral glucocorticoids, nonsteroidal anti-inflammatory drugs, and methotrexate. Just after...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. I. Alekseeva, S. I. Valieva, T. M. Bzarova, R. V. Denisova, T. V. Sleptsova, O. L. Lomakina, A. M. Chomakhidze
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2016-11-01
Series:	Педиатрическая фармакология
Subjects:	tocilizumab juvenile idiopathic arthritis children
Online Access:	https://www.pedpharma.ru/jour/article/view/1447
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CLINICAL CASE OF USING TOCILIZUMAB FOR A FEMALE PATIENT WITH AN EARLY DEBUT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: О. L. Lomakina, et al.
Published: (2014-10-01)

CLINICAL CASE OF TOCILIZUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: O. L. Lomakina, et al.
Published: (2014-01-01)

A HISTORY CASE OF TOCILIZUMAB USAGE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2012-07-01)

CLINICAL CASE OF TOCILIZUMAB THERAPY IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-07-01)

Retrospective Analysis of Efficacy and Safety of Tocilizumab Treatment in Children with Severe Systemic Juvenile Idiopathic Arthritis: 12-month Follow-up
by: A. A. Baranov, et al.
Published: (2013-03-01)

THE PHENOMENON OF NEUTROPENIA DURING TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
by: M. I. Kaleda, et al.
Published: (2018-01-01)

Comparison of different treatment modalities of tocilizumab in children with systemic juvenile idiopathic arthritis
by: M. M. Kostik, et al.
Published: (2013-09-01)

COMPARATIVE EVALUATION OF THE EFFICIENCY AND SAFETY OF TREATING CHILDREN WITH POLYARTICULARY JUVENILE IDIOPATHIC ARTHRITIS WITH METHOTREXATE AND WITH METHOTREXATE COMBINED WITH TOCILIZUMAB
by: V. A. Kel'tsev, et al.
Published: (2015-04-01)

THE EFFECT OF TOCILIZUMAB ON THE CONDITION OF BONE TISSUE OF PATIENTS WITH SYSTEMATIC JUVENILE IDIOPATIC ARTHRITIS: RESULTS OF A SERIES OF CASES RETROSPECTIVE STUDY
by: M. S. Shingarova, et al.
Published: (2017-02-01)

Clinical Case of Tocilizumab Use in a Patient with Systemic Juvenile Idiopathic Arthritis
by: Y. M. Spivakovskiy, et al.
Published: (2016-02-01)

The Use of Tocilizumab in 40 Patients With Polyarticular Juvenile Idiopathic Arthritis: the Results of a Retrospective Study
by: Mikhail M. Kostik, et al.
Published: (2017-06-01)

Experience in the use of tocilizumab in patient with systemic juvenile idiopathic arthritis and type 1 diabetes
by: E. A. Ligostaeva, et al.
Published: (2016-06-01)

Evaluation of the efficiency and safety of tocilizumab therapy in patients with systemic-onset juvenile idiopathic arthritis: results of a retrospective follow-up
by: M. M. Kostik, et al.
Published: (2018-01-01)

Optimization of systemic juvenile arthritis treatment regimens with correction of tocilizumab intravenous administration according to data of observational retrospective study
by: M. I. Kaleda, et al.
Published: (2019-05-01)

Experience of the Tocilizumab Application in Systemic Onset Juvenile Arthritis
by: A. V. Krasnopol’skaja, et al.
Published: (2015-11-01)

PROGNOSTIC FACTORS FOR THE RESPONSE TO TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS: A COHORT STUDY
by: Ekaterina I. Alexeeva, et al.
Published: (2018-07-01)

ADALIMUMAB IN TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-12-01)

Experience of Using Tocilizumab in a Patient with Polyarticular Juvenile Rheumatoid Arthritis with Cervical Spine Lesions
by: E. A. Ligostaeva, et al.
Published: (2015-11-01)

EXPERIENCE OF USING DRUG TOCILIZUMAB IN A BOY WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E. S. Zholobova, et al.
Published: (2013-11-01)

Review of International Registers of Patients with Systemic Juvenile Idiopathic Arthritis
by: Ekaterina I. Alekseeva, et al.
Published: (2017-04-01)

EXPERIENCE IN APPLICATION OF TOCILIZUMAB AT SYSTEM VARIANT OF JUVENILE IDIOPATHIC ARTHRITIS IN THE REPUBLIC OF BASHKORTOSTAN
by: V. А. Malievskii, et al.
Published: (2014-05-01)

Dynamics of Destructive Joint Changes in Juvenile Idiopathic Arthritis in Children who Received Methotrexate or Methotrexate-Tocilizumab Combination: a Cohort Study
by: Maria A. Davydova, et al.
Published: (2018-01-01)

EXPERIENCE OF RITUXIMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alekseeva, et al.
Published: (2012-08-01)

EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICE
by: M. I. Kaleda, et al.
Published: (2015-04-01)

EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
by: K. B. Isaeva, et al.
Published: (2014-07-01)

EXPERIENCE OF APPLYING MONOCLONAL ANTIBODIES TO TNF α — ADALIMUMAB — IN A CHILD WITH JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-07-01)

LONG TERM FOLLOW-UP ON EFFECTIVENESS AND SAFETY OF ETANERCEPT IN JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS
by: A. A. Baranov, et al.
Published: (2015-04-01)

CLINICAL CASE: USE OF CANAKINUMAB IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS RESISTANT TO IMMUNOSUPPRESSANTS AND GENETICALLY ENGINEERED BIOPHARMACEUTICALS
by: E. I. Alexeeva, et al.
Published: (2014-03-01)

EXPERIENCE OF METHOTREXATE USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Sleptsova, et al.
Published: (2013-09-01)

Evaluation of Efficacy and Safety of Etanercept Therapy in Patients with Early and Late Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2015-09-01)

Evaluation of Efficacy and Safety of Etanercept and Etanercept + Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2016-01-01)

EXPERIENCE OF INTRAMUSCULAR METHOTREXATE USE IN A PATIENT WITH EARLY POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2014-03-01)

CLINICAL CASE OF CANAKINUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-09-01)

Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study
by: Ekaterina I. Alexeeva, et al.
Published: (2020-08-01)

EFFICACY AND SAFETY OF PEDIATRIC JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS TREATMENT WITH ADALIMUMAB
by: E. I. Alexeeva, et al.
Published: (2012-01-01)

RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF HYPODERMIC METHOTREXATE INJECTIONS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-07-01)

ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH THE JUVENILE IDIOPATHIC ARTHRITIS TREATED BY THE ETANERCEPT
by: A. N. Fetisova, et al.
Published: (2014-07-01)

Efficacy and Safety of Adalimumab Long-Term Administration with Immunosuppressants at Juvenile Idiopathic Arthritis without Systemic Manifestations
by: E. I. Alexeeva, et al.
Published: (2015-09-01)

EXPERIENCE OF ABATACEPT TREATMENT IN A PATIENT WITH ANTIBODY-POSITIVE IDIOPATHIC JUVENILE ARTHRITIS
by: T. M. Bzarova, et al.
Published: (2012-03-01)

Experience of Parenteral Administration of Methotrexate in a Female Patient Suffering from Early Juvenile Idiopathic Arthritis and Uveitis
by: Т. V. Sleptsova, et al.
Published: (2015-08-01)